Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2026-07-01 @ 1:43 PM
Study NCT ID:
NCT00419367
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2022-09-22
First Post:
2007-01-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Compassionate Use of Vorinostat for the Treatment of Patients With Advanced Cutaneous T-Cell Lymphoma (0683-042)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
0683-042
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None